Stoke Therapeutics, Inc. · NASDAQ:STOK

Ticho Barry sold 1,838 Stoke Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 1,838 Stoke Therapeutics, Inc. shares at US$32.66 for US$60,029 under a trading plan, leaving 38,864 shares. Filed Apr 3, 2026 (Form 4).

Sold
1,838 shares
Price
US$32.66
Value
US$60,029
Holding after
38,864 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockSale1,838US$32.6638,864Direct

Source

View original at SEC

Related